![[사회]Controversy about the effects of AstraZeneca elderly people…](https://image.ytn.co.kr/general/jpg/2021/0129/202101292203277762_t.jpg "[사회]Controversy about the effects of AstraZeneca elderly people…")
Germany recommends AstraZeneca vaccine only for those under 65 years old
Government also watched for controversy ahead of AstraZeneca vaccination next month
Ministry of Food and Drug Safety, More AstraZeneca Vaccine Verification Advisory Committee Meeting
[앵커]
In the next month, AstraZeneca’s COVID-19 vaccine will begin.
Vulnerable groups, such as the elderly, are first met, but the controversy over the prevention effect of the elderly is divided.
Germany advised against vaccinating elderly people at all.
Reporter Hyungwon Lee reported whether there would be any problems with the inoculation plan in Korea.
[기자]
Amid controversy about the effects of the AstraZeneca vaccine on the elderly, the German government has only recommended vaccinations under 65
It’s not because the effect on the elderly is insignificant, but that there is too little evidence to discuss this effect itself.
[정재훈 / 가천대 의대 예방의학과 교수 : 아스트라제네카에 대한 독일 규제 당국의 발표는 백신 효과에 대한 문제가 아니라 충분한 고령층 데이터가 부족하다는 의미이고요.]
The Korean government is also watching this controversy, ahead of the AstraZeneca vaccination next month.
This is because most of the vulnerable people, including those in nursing hospitals who are subject to vaccination, are elderly.
Expert opinions diverged about whether it was right to inoculate as planned.
[정재훈 / 가천대 의대 예방의학과 교수 : 이미 영국과 인도에서 고령층을 대상으로 접종이 이뤄지고 있고, 아스트라제네카 백신은 사망 예방에 뛰어난 효과를 보이기 때문에 결국은 중증 (악화를) 방지하는 의미에서 접종이 진행돼야 합니다.]
Some point out that unlike Israel, where the Pfizer vaccine has been proven effective in the elderly, no actual vaccination has been disclosed in the UK.
[김우주 / 고대 구로병원 감염내과 교수 : 영국 고령자에서 아스트라제네카 백신 얼마나 놨고, 효과는 어떻고 안전성은 어떻고, 이게 자료가 나와야 하는데 안 나오잖아요. (임상) 효능도 지금 이게 65세 이상에서 입증이 안 된 상황인데, 과연 접종해도 되느냐….]
The Ministry of Food and Drug Safety holds a meeting of the’Corona 19 Vaccine Verification Advisory Group’ the day after tomorrow (31st) to review the data of the AstraZeneca clinical trial.
At the meeting, recent overseas trends are also reviewed, and the results of the discussion will be released the next day.
An official from the Ministry of Food and Drug Safety said it would decide whether to approve AstraZeneca vaccine after going through additional procedures such as the Central Pharmacy Review Committee and the Final Inspection Committee after the advisory group meeting.
YTN Hyungwon Lee[[email protected]]is.
※’Your report becomes news’ YTN is waiting for your valuable report.
[카카오톡] Search YTN to add a channel [전화] 02-398-8585 [메일] [email protected] [온라인 제보] www.ytn.co.kr
[저작권자(c) YTN & YTN plus 무단전재 및 재배포 금지]
– .
